Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taruna Arora

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Biochemical and Biophysical Research Communications|April 8, 2021
NLRP3 inflammasome and bruton tyrosine kinase inhibition interferes with upregulated platelet aggregation and in vitro thrombus formation in sickle cell miceSebastian Vogel, Sayuri Kamimura, Taruna Arora, et al.
Trials|July 18, 2023
Individualized lifestyle intervention in PCOS women (IPOS): a study protocol for a multicentric randomized controlled trial for evaluating the effectiveness of an individualized lifestyle intervention in PCOS women who wish to conceiveNeena Malhotra, Taruna Arora, Vanita Suri, et al.
Trials|July 31, 2023
Publisher Correction: Individualized lifestyle intervention in PCOS women (IPOS): a study protocol for a multicentric randomized controlled trial for evaluating the effectiveness of an individualized lifestyle intervention in PCOS women who wish to conceiveNeena Malhotra, Taruna Arora, Vanita Suri, et al.
The Journal of Pharmacy and Pharmacology|May 25, 2023
Effect of vinpocetine alone and in combination with enalapril in experimental model of diabetic cardiomyopathy in rats: possible involvement of PDE-1/TGF-β/ Smad 2/3 signalling pathwaysVishal Kumar Vishwakarma, Sadia Shah, Tajpreet Kaur, et al.
Blood Advances|October 19, 2018
The platelet NLRP3 inflammasome is upregulated in sickle cell disease via HMGB1/TLR4 and Bruton tyrosine kinaseSebastian Vogel, Taruna Arora, Xunde Wang, et al.
Oncology Reports|June 14, 2022
miRNAs and the Hippo pathway in cancer: Exploring the therapeutic potential (Review)Taruna Arora, Mohd Adnan Kausar, Shimaa Mohammed Aboelnaga, et al.
BMC Women'S Health|March 8, 2025
Cardiometabolic markers and serum amh levels in PCOS: can AMH serve as a surrogate cardiometabolic markeR?Mohammad Ashraf Ganie, Neena Malhotra, Puthiyaveetil Khadar Jabbar, et al.
JMIR Public Health and Surveillance|September 6, 2023
Prevalence, Regional Variations, and Predictors of Overweight, Obesity, and Hypertension Among Healthy Reproductive-Age Indian Women: Nationwide Cross-Sectional Polycystic Ovary Syndrome Task Force StudyMohd Ashraf Ganie, Subhankar Chowdhury, Vanita Suri, et al.
Cancer Research|April 15, 2014
Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19Mei Zhou, Xueyan Wang, Van Phung, et al.
Journal of Pharmaceutical Sciences|August 9, 2013
Development of a human antibody tolerant mouse model to assess the immunogenicity risk due to aggregated biotherapeuticsVivian Bi, Vibha Jawa, Marisa K Joubert, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Biochemical and Biophysical Research Communications|April 8, 2021
NLRP3 inflammasome and bruton tyrosine kinase inhibition interferes with upregulated platelet aggregation and in vitro thrombus formation in sickle cell miceSebastian Vogel, Sayuri Kamimura, Taruna Arora, et al.
Trials|July 18, 2023
Individualized lifestyle intervention in PCOS women (IPOS): a study protocol for a multicentric randomized controlled trial for evaluating the effectiveness of an individualized lifestyle intervention in PCOS women who wish to conceiveNeena Malhotra, Taruna Arora, Vanita Suri, et al.
Trials|July 31, 2023
Publisher Correction: Individualized lifestyle intervention in PCOS women (IPOS): a study protocol for a multicentric randomized controlled trial for evaluating the effectiveness of an individualized lifestyle intervention in PCOS women who wish to conceiveNeena Malhotra, Taruna Arora, Vanita Suri, et al.
The Journal of Pharmacy and Pharmacology|May 25, 2023
Effect of vinpocetine alone and in combination with enalapril in experimental model of diabetic cardiomyopathy in rats: possible involvement of PDE-1/TGF-β/ Smad 2/3 signalling pathwaysVishal Kumar Vishwakarma, Sadia Shah, Tajpreet Kaur, et al.
Blood Advances|October 19, 2018
The platelet NLRP3 inflammasome is upregulated in sickle cell disease via HMGB1/TLR4 and Bruton tyrosine kinaseSebastian Vogel, Taruna Arora, Xunde Wang, et al.
Oncology Reports|June 14, 2022
miRNAs and the Hippo pathway in cancer: Exploring the therapeutic potential (Review)Taruna Arora, Mohd Adnan Kausar, Shimaa Mohammed Aboelnaga, et al.
BMC Women'S Health|March 8, 2025
Cardiometabolic markers and serum amh levels in PCOS: can AMH serve as a surrogate cardiometabolic markeR?Mohammad Ashraf Ganie, Neena Malhotra, Puthiyaveetil Khadar Jabbar, et al.
JMIR Public Health and Surveillance|September 6, 2023
Prevalence, Regional Variations, and Predictors of Overweight, Obesity, and Hypertension Among Healthy Reproductive-Age Indian Women: Nationwide Cross-Sectional Polycystic Ovary Syndrome Task Force StudyMohd Ashraf Ganie, Subhankar Chowdhury, Vanita Suri, et al.
Cancer Research|April 15, 2014
Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19Mei Zhou, Xueyan Wang, Van Phung, et al.
Journal of Pharmaceutical Sciences|August 9, 2013
Development of a human antibody tolerant mouse model to assess the immunogenicity risk due to aggregated biotherapeuticsVivian Bi, Vibha Jawa, Marisa K Joubert, et al.
Pageof 5